IBRUTINIB FOR THE TREATMENT OF RELAPSED/REFRACTORY PRIMARY OR SECONDARY CENTRAL NERVOUS SYSTEM LARGE B‐CELL LYMPHOMAS: EXPERIENCE FROM THE GELTAMO GROUP | Publicación